Medication info

Telcadin Plus F Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Kyungdong Pharm. Co., Ltd.
Appearance
Oval-shaped tablets consisting of a white/pink two-layer structure with possible pink specks in the white layer.
Packaging
30 tablets (10 tablets/Alu-Alu X 3)
Approval status
Expired

MFDS item code 201209719 · Approved 2012.12.14

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, direct conversion from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate medicines or as a combination medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Do not administer more than 40/12.5mg per day of this medicine to patients with mild to moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment. Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Kyungdong Pharm. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by telmisartan alone

  • Essential hypertension
View approved original text

Used for the treatment of essential hypertension; it effectively manages blood pressure when administered in combination with Telmisartan for patients whose blood pressure is poorly controlled.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, direct conversion from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate medicines or as a combination medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Do not administer more than 40/12.5mg per day of this medicine to patients with mild to moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment. Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can have serious effects on the fetus during pregnancy, particularly in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Do not use this medication if you have allergies to any of its ingredients or additives, are in the second or third trimester of pregnancy, are breastfeeding, or have conditions such as cholestasis, biliary obstruction, severe liver or kidney impairment. Elderly patients or those with high potassium levels, liver impairment, heart valve disease, ischemic heart disease, gastrointestinal diseases, or renal vascular hypertension should be particularly cautious when using this drug. This medication can cause various side effects such as dizziness, hypotension, electrolyte imbalance, skin rash, muscle pain, and dyspepsia, so any abnormal symptoms should prompt immediate consultation with a doctor. Particularly, as there may be an increased risk of skin cancer, exposure to sunlight should be minimized, and any skin abnormalities should be reported to healthcare professionals. This medication may interact with other blood pressure medications, lithium, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs, etc., so it is essential to inform your doctor about any other medications you are taking. It should not be used during pregnancy or breastfeeding, and alternative treatments should be discussed if you are planning to become pregnant or are already pregnant. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, necessitating immediate medical attention. Safety and efficacy have not been established for children under 18 years, so it is not recommended for use in this age group. Elderly patients should be cautious when taking this medication due to the risk of excessive blood pressure lowering, which can lead to conditions like cerebral infarction.

Side effects

Hypotension, neonatal skull formation deficiency, anuria, renal failure, oligohydramnios, limb convulsion, craniofacial malformation, pulmonary hypoplasia, premature, intrauterine growth retardation, patent ductus arteriosus, bronchitis, pharyngitis, sinusitis, exacerbation or activation of systemic lupus erythematosus, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, dizziness, syncope, paresthesia, insomnia, sleep disorders, visual disturbances, transient blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, pneumonia, pulmonary edema, diarrhea, dry mouth, abdominal distention, abdominal pain, constipation, dyspepsia, vomiting, gastritis, liver function abnormalities, liver disorders, angioedema, erythema, pruritus, rash, increased sweating, urticaria, low back pain, muscle cramps, myalgia, arthralgia, limb pain, erectile dysfunction, chest pain, influenza-like illness, pain, increased serum uric acid, increased serum creatinine, increased serum creatine phosphokinase, upper respiratory tract infection, urinary tract infection, sepsis, anemia, eosinophilia, thrombocytopenia, anaphylactic reaction, hypersensitivity, hyperkalemia, hypoglycemia, bradycardia, abdominal discomfort, eczema, drug rash, toxic skin rash, arthritis, tendon pain, renal dysfunction, asthenia, decreased hemoglobin, sialadenitis, aplastic anemia, hemolytic anemia, bone marrow dysfunction, leukopenia, neutropenia, agranulocytosis, necrotizing vasculitis, pancreatitis, hepatocellular jaundice, cholestatic jaundice, toxic epidermal necrolysis, cutaneous lupus erythematosus-like reaction, cutaneous vasculitis, phototoxic reaction, reactivation of cutaneous lupus erythematosus, weakness, interstitial nephritis, renal impairment, diabetes, fever, increased triglycerides, acute respiratory distress syndrome, nausea, gastrointestinal bleeding, esophagitis, headache, tremor, facial flushing, malaise, fatigue, weight loss, proteinuria, itchiness, myalgia, floating sensation, lip and hand tremors, sensory hyperreactivity, vision loss, hypoglycemia, acute myopia, acute angle-closure glaucoma, pulmonary edema, fever, hypochloremic alkalosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a sealed container. Additionally, it should be kept at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.

Appearance and packaging

Appearance

Oval-shaped tablets consisting of a white/pink two-layer structure with possible pink specks in the white layer.

Package unit

30 tablets (10 tablets/Alu-Alu X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.